Nevertheless, we cannot rule out that the high non-Cp Cu serum concentration (4 μmol/L, Table 6) of the patient carrying the RGS7 loss-stop variant, along with other RGS7 altered mechanisms, could have had effects in accelerating AD pathogenesis. This evidence concerns the gene RGS7 and Alzheimer disease.